| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/01/2010 | US20100080828 Immunogenic sequences |
| 04/01/2010 | US20100080824 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies |
| 04/01/2010 | US20100080819 Modulators of p-selectin glycoprotein ligand 1 |
| 04/01/2010 | US20100080809 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 04/01/2010 | US20100080804 Methods of treating inflammatory disorders of the lungs |
| 04/01/2010 | US20100080799 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity |
| 04/01/2010 | US20100080793 DcR3 polypeptide, A TNFR homolog |
| 04/01/2010 | US20100080784 Methods for treating cachexia and lymphopenia |
| 04/01/2010 | US20100080780 Pluripotent autologous stem cells from oral mucosa and methods of use |
| 04/01/2010 | US20100078324 Electrochemical cell |
| 04/01/2010 | DE102008059985B3 Real-Time-PCR mittels Gigahertz- oder Terahertz-Spektrometrie Real-time PCR using gigahertz or terahertz spectroscopy |
| 04/01/2010 | DE102008049601A1 Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay Antibodies for determination of prothrombin fragment F2 / F1 + 2 in a homogeneous immunoassay |
| 04/01/2010 | DE102006021761B4 Biomolekulare Recheneinheit Biomolecular computing unit |
| 04/01/2010 | DE102006021493B4 Massenspektrometrische Messung mikrobieller Resistenzen Mass spectrometric measurement of microbial resistance |
| 04/01/2010 | DE102005060925B4 Verfahren zur Detektion von DNA-Basensequenzveränderungen A method for detecting DNA base sequence changes |
| 04/01/2010 | CA2776044A1 Screening methods for identifying specific staphylococcus aureus inhibitors |
| 04/01/2010 | CA2743354A1 Oligonucleotidic sequences able to silence the expression of the cyclin d1 -trop2 chimera and uses thereof in medical field |
| 04/01/2010 | CA2739171A1 Biomarker for microdomain diease |
| 04/01/2010 | CA2738474A1 Soybean transgenic event mon87705 and methods for detection thereof |
| 04/01/2010 | CA2738427A1 A method of detecting antibodies and antibody-hiv virion complexes |
| 04/01/2010 | CA2738287A1 Method for detecting analytes |
| 04/01/2010 | CA2738264A1 Kits and devices for detecting analytes |
| 04/01/2010 | CA2738207A1 In vitro method and kit for prognosis or prediction of the response of rheumatoid arthritis patients to treatment with tnf-alpha factor blocking agents |
| 04/01/2010 | CA2738129A1 Aptamer for ngf and use thereof |
| 04/01/2010 | CA2737903A1 Methods for identifying the habitats of insects |
| 04/01/2010 | CA2737795A1 Nitrogen responsive early nodulin gene |
| 04/01/2010 | CA2737669A1 Combinatorial synthesis and use of libraries of short expressed nucleic acid sequences for the analysis of cellular events |
| 04/01/2010 | CA2737031A1 Indole and indoline derivatives and methods of use thereof |
| 04/01/2010 | CA2736373A1 Methods for treating, diagnosing, and monitoring lupus |
| 03/31/2010 | EP2169403A1 Method of measuring microparticles having nucleic acid and apparatus therefor |
| 03/31/2010 | EP2169078A1 Methods and kits for the diagnosis and the staging of colorectal cancer |
| 03/31/2010 | EP2169077A1 Methods and compositions for diagnosing an adenocarcinoma |
| 03/31/2010 | EP2169076A2 Enzymes having alpha amylase activity and methods of use thereof |
| 03/31/2010 | EP2169059A1 Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis |
| 03/31/2010 | EP2169056A1 Set of yeast cells, method of identifying target candidate molecule, method of analyzing action mechanism and screening method |
| 03/31/2010 | EP2169051A1 Method for induction of differentiation of es cell |
| 03/31/2010 | EP2169047A2 Microbial detection assembly |
| 03/31/2010 | EP2168973A1 Nucleic acid ligand complexes |
| 03/31/2010 | EP2168949A1 Method for electrochemical detection of sequences of nucleic acids |
| 03/31/2010 | EP2168499A1 Method for acquiring biological rhythm information |
| 03/31/2010 | EP2167978A2 Method for determining von willebrand factor activity in the absence of ristocetin and for determining the adamts-13 protease |
| 03/31/2010 | EP2167970A2 Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer |
| 03/31/2010 | EP2167968A1 Method for the multiplex serological diagnosis in vitro of spirochete infections |
| 03/31/2010 | EP2167692A2 Cd44 splice variants in neurodegenerative diseases |
| 03/31/2010 | EP2167690A2 Androgen-dependent 1-f-aromatase reporter gene |
| 03/31/2010 | EP2167689A2 Recurrent gene fusions in prostate cancer |
| 03/31/2010 | EP2167688A1 Targeted cell death |
| 03/31/2010 | EP2167687A2 Biomarkers for predicting anti-tnf responsiveness or non-responsiveness |
| 03/31/2010 | EP2167686A1 Compositions |
| 03/31/2010 | EP2167685A1 Method and probe/primer system for the "real time" detection of a nucleic acid target |
| 03/31/2010 | EP2167684A2 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 03/31/2010 | EP2167683A2 Method to predict or diagnose a gastrointestinal disorder or disease |
| 03/31/2010 | EP2167682A1 System substitute pcr |
| 03/31/2010 | EP2167681A1 Treatment of cardiovascular disease with salicylates |
| 03/31/2010 | EP2167680A1 Device and a method for the detection and amplification of a signal |
| 03/31/2010 | EP2167679A2 Compositions and methods for diagnosing and assesing inflammatory myopathies |
| 03/31/2010 | EP2167678A2 A method of detecting and separating serum gamma-glutamyl transferase (ggt) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained |
| 03/31/2010 | EP2167677A2 Target enzyme in the treatment of acne |
| 03/31/2010 | EP2167676A1 Combined method and kit for the sequential measurement of (1) the enzymatically active fraction and (2) the total amount of an enzyme |
| 03/31/2010 | EP2167659A2 Genetic markers associated with endometriosis and use thereof |
| 03/31/2010 | EP2167634A2 Arrays, substrates, devices, methods and systems for detecting target molecules |
| 03/31/2010 | EP2167524A1 Methods of directly amplifying nucleic acids from crude samples |
| 03/31/2010 | EP2167519A1 Nucleic acid packaging system |
| 03/31/2010 | EP2167075A1 Mixed lineage kinases and metabolic disorders |
| 03/31/2010 | EP2167057A1 Pde inhibitors for the treatment of hearing impairment |
| 03/31/2010 | EP1793004B1 Method of forming signal probe polymer |
| 03/31/2010 | EP1680517B1 Concatameric ligation products: compositions, methods and kits for same |
| 03/31/2010 | EP1530724B1 Diagnosis and prevention of cancer cell invasion |
| 03/31/2010 | EP1379126B9 Novel endophytic fungi and methods of use |
| 03/31/2010 | EP1194168B1 Methods and products for manipulating uncoupling protein expression |
| 03/31/2010 | CN101688861A Reaction vessel with integrated optical and fluid control elements |
| 03/31/2010 | CN101688859A modulation of sperm motility |
| 03/31/2010 | CN101688327A Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 03/31/2010 | CN101688253A antitoxin destabilization technology |
| 03/31/2010 | CN101688252A In vivo expression analysis using ultrasound-induced transfection of reporter constructs |
| 03/31/2010 | CN101688251A Methods and compositions related to riboswitches that control alternative splicing and rna processing |
| 03/31/2010 | CN101688250A Nucleic-acid amplification judging method and nucleic-acid amplification judging device |
| 03/31/2010 | CN101688249A Increasing grain yield through targeted reduction in ethylene signaling |
| 03/31/2010 | CN101688248A Androgen-dependent gene fusion comprising the 1f aromatase promoter and a reporter gene |
| 03/31/2010 | CN101688247A methods and compositions for diagnosing osteoarthritis in a feline |
| 03/31/2010 | CN101688246A Synthetic expression vectors for insect cells |
| 03/31/2010 | CN101688245A Methods for diagnosing ischemia |
| 03/31/2010 | CN101688244A Stable recombinant adenosine deaminase |
| 03/31/2010 | CN101688243A Involvement of lipid kinase, and signal transduction pathway comprising said lipid kinase, in resistance to her2-targeting therapy |
| 03/31/2010 | CN101688242A primers for detecting plasmodium |
| 03/31/2010 | CN101688241A Cultures with improved phage resistance |
| 03/31/2010 | CN101688240A Predicting post-treatment survival in cancer patients with micrornas |
| 03/31/2010 | CN101688239A Early detection and prognosis of colon cancers |
| 03/31/2010 | CN101688238A Methods of producing haploid and doubled haploid oil palms |
| 03/31/2010 | CN101688237A Circular chromosome conformation capture (4c) |
| 03/31/2010 | CN101688236A Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| 03/31/2010 | CN101688235A Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof |
| 03/31/2010 | CN101688234A Methods for modulating lrrk2 |
| 03/31/2010 | CN101688233A Method of bioassaying yokkansan |
| 03/31/2010 | CN101688232A Biochip for quantifying amino acid and method for analying amino acid using the same |
| 03/31/2010 | CN101688231A Allosteric trans-splicing group i ribozyme whose activity of target-specific rna replacement is controlled by theophylline |
| 03/31/2010 | CN101688230A Method for screening immune modulator |
| 03/31/2010 | CN101688219A Novel herbicide resistance genes |
| 03/31/2010 | CN101688213A Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| 03/31/2010 | CN101688207A A gastric carcinoma gene znf312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same |